Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|March 26, 2022
Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancerSuzette Delaloge, Sylvain Dureau, Véronique D'Hondt, et al.Molecular Oncology|November 12, 2022
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO groupNour-El-Houda Mourksi, Cécile Dalban, Amélie Colombe-Vermorel, et al.International Journal of Cancer|May 16, 2019
Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME programWilliam Jacot, Pierre-Etienne Heudel, Julien Fraisse, et al.Breast Cancer (Tokyo, Japan)|January 5, 2023
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patientsCaroline Bailleux, Antoine Arnaud, Jean-Sébastien Frenel, et al.Breast (Edinburgh, Scotland)|November 28, 2025
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03Olivier Trédan, Delphine Loirat, Sylvie Chabaud, et al.British Journal of Cancer|September 30, 2021
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemicAlexandra Bizot, Maryam Karimi, Elie Rassy, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2019
Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trialAude-Marie Foucaut, Magali Morelle, Anne-Sophie Kempf-Lépine, et al.Breast Cancer Research : BCR|January 20, 2021
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre studyMarion Alhenc-Gelas, Luc Cabel, Frederique Berger, et al.Journal of Personalized Medicine|October 27, 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 TrialElise Bonnet, Véronique Haddad, Stanislas Quesada, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2017
Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian CancerS Intidhar Labidi-Galy, Timothée Olivier, Manuel Rodrigues, et al.Pageof 6